Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
  • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
  • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
  • C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
  • C07D317/34—Oxygen atoms
  • C07D317/36—Alkylene carbonates; Substituted alkylene carbonates
  • C07D317/38—Ethylene carbonate
• • C—CHEMISTRY; METALLURGY
  • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
  • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
  • C08G18/00—Polymeric products of isocyanates or isothiocyanates
  • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
  • C08G18/08—Processes
  • C08G18/10—Prepolymer processes involving reaction of isocyanates or isothiocyanates with compounds having active hydrogen in a first reaction step

Definitions

• 2-Oxo-l ,3-dioxolane-4-carboxamide building blocks their preparation and use
• the present invention relates to a 2-oxo-1 ,3-dioxolane-4-carboxamide of formula (I),
• R is an n-valent radical
• n is an integer from 2 to 4, preferably 2 to 3
• x is an integer from 1 to n-1 , to a process for the preparation of a 2-oxo-1 ,3-dioxolane-4- carboxamide of formula (I) by reaction of 2-oxo-1 ,3-dioxolane-4-carboxylic acid of formula (II)
• R2 can be, inter alia, an n-valent radical (n > 1 ) which is substituted with n-1 further 2-Oxo-l ,3-dioxolane-4-carboxamide groups of general formula (IV), processes for the preparation of these 2-oxo-1 ,3-dioxolane-4-carboxamides, processes for the preparation of the 2-oxo-1 ,3-dioxolane-4-carboxylic acids of formula (V),
• R 4 may be hydrogen, straight-chain or branched Ci-s-alkyl, C5-i2-cycloalkyl or C6-i5-aryl.
• R3 may be straight-chain or branched Ci-8-alkyl or C6-is-aryl.
• WO 2004/003001 A1 describes the enzymatic race- mate separation of the enantiomers of type (VI) but without indicating a synthesis for these compounds.
• EP 1941946 A1 describes the use of a carbonitride catalyst inter alia for the preparation of certain disubstituted organic carbonates.
• These may also be compounds of the general formula (VII), where R 10 and R 11 , independently of one another, are selected optional substituents.
• Possible meanings of the substituents are alkyl, aryl, herteroaryl and ester groups CO2A, where A may in turn be alkyl or aryl, e.g. straight-chain or branched Ci-6-alkyl, preferably Ci-3-alkyl and particularly preferably methyl or ethyl.
• no syntheses for 2-OXO-1 ,3-dioxolane systems are stated.
• JP 2006-003433 A discloses a sealing composition for liquid crystal display elements which comprises a compound of the general formula (VIII),
• R is H, a hydroxyl group, a cyano group, a carboxylic acid group, an optionally substituted aromatic ring, a straight-chain, branched or cyclic alkyl group, an acyl group or an ester group.
• EP 0001088 A1 describes inter alia 2-oxo-1 ,3-dioxolanes of the general formula (IX), where R can be H or CH3.
• EP 2397474 A1 describes 2-oxo-1 ,3-dioxolane-4-carboxylic acid esters of formula (X) in which Ri may be inter alia Me or Et or an n-valent radical which may be substituted with a maximum of n-1 further 2-oxo-1 ,3-dioxolane-4-carboxyl groups, a process for their preparation by means of carboxylation of the corresponding epoxides, a process for their transesterification, and also their use for the preparation of hydroxyurethanes and as end groups for the blocking of amines.
• Ri may be inter alia Me or Et or an n-valent radical which may be substituted with a maximum of n-1 further 2-oxo-1 ,3-dioxolane-4-carboxyl groups
• At least one of the radicals W1 or W1 a comprises a protected glycoside, and each of the radicals W1 and W1 a, independently of one another, may inter alia also be an amide group.
• Polyurethanes based on polyisocyanates are a widely applied polymer family. These polymers are used for shoes, mattresses, automotive parts, sports equipment, artificial leather and the like. Also in construction chemistry they are one of the most widely applied materials e.g. for sealants, adhesives, coatings and foams in areas like mining, roofing, flooring, tile fixing, and waterproofing, to name a few. The high resistance to acids, alkalis and chemicals of the cured compositions obtained in this way are advantageous.
• the present invention thus provides a 2-oxo-1 ,3-dioxolane-4-carboxamide of formula (I),
• R is an n-valent radical
• n is an integer from 2 to 4
• x is an integer from 1 to n-1 .
• n-valent radical generally means that R is a group which is substituted with n substituents.
• R is a group which has a valency of "n”.
• n can be an integer from 2 to 3.
• R would be a n-valent polyisocyanate after the abstraction of the -NCO groups.
• abtraction does not refer to a chemical operation but simply to formally taking away the -NCO groups from a chemical formula of a polyiso- cyanate.
• n is equal to 2 or 3
• x is equal to 1 or 2.
• the polyisocyanates according to the invention are also intended to include dimers (uretdiones) and trimers (isocyanurates). Particular importance is attributed here to the HDI trimer.
• prepolymers of polyisocyanates with polyols can also be used if a stoichiometric excess of NCO groups is present.
• Suitable polyols include polyoxyalkylene poly- ols (also called “polyether polyols”), which can contain inter alia ethylene oxide units, propylene oxide units and butylene oxide units, aliphatic diols and polyols, and also polyester polyols and polycarbonate polyols, castor oil, hydrogenated castor oil, (hy- droxylated epoxidized) soya oil, and also mixtures of the aforementioned polyols.
• polyoxyalkylene poly- ols also called “polyether polyols”
• polyether polyols also called "polyether polyols”
• polyester polyols and polycarbonate polyols castor oil, hydrogenated castor oil, (hy- droxylated epoxidized) soya oil, and also mixtures of the aforementioned polyols.
• polyisocyanates A small selection of commercially available polyisocyanates would include tetramethyl- ene 1 ,4-diisocyanate, 2-methylpentamethylene 1 ,5-diisocyanate, hexamethylene 1 ,6- diisocyanate (HDI), 2,2,4- and 2,4,4-trimethylhexamethylene 1 ,6-diisocyanate (TMDI), dodecamethylene 1 ,12-diisocyanate, lysine diisocyanate and lysine ester diisocyanate, 1 -isocyanato-3,3,5-trimethyl-5-isocyanatomethylcyclohexane (isophorone diisocyanate - IPDI), 1 ,4-diisocyanato-2,2,6-trimethylcyclohexane (TMCDI), 2,2'-, 2,4'- and 4,4'-di- cyclohexylmethane diisocyanate (
• R can be defined as being selected from straight-chain, branched or cyclic C2-22-alkylene groups, C6-2o-arylene groups, C6-2o-alkarylene groups, polyether groups, polycarbonate groups, polyester groups, poly(meth)acrylate groups, and combinations thereof.
• the present invention furthermore provides a process for the preparation of a 2-oxo- 1 ,3-dioxolane-4-carboxamide according to the invention, characterized in that 2-oxo- 1 ,3-dioxolane-4-carboxylic acid of formula (II)
• Preferred catalysts are selected from dimethylcyclohexylamine, 4-dimethylaminopyri- dine (DMAP), diazabicyclooctane (DABCO), diazabicycloundecene (DBU), dibutyltin dilaurate (DBTL), a bismuth carboxylate such as bismuth octanoate or bismuth neode- canoate, a titanium or zirconium alkoxylate or carboxylate, and mixtures thereof.
• DMAP dimethylcyclohexylamine
• DMAP diazabicyclooctane
• DBU diazabicycloundecene
• DBTL dibutyltin dilaurate
• a bismuth carboxylate such as bismuth octanoate or bismuth neode- canoate
• titanium or zirconium alkoxylate or carboxylate and mixtures thereof.
• the present invention provides for the use of a 2-oxo-1 ,3-dioxolane-4- carboxamide for the preparation of a 2-oxo-1 ,3-dioxolane-4-carboxamide-substituted prepolymer (i.e. a binder).
• a 2-oxo-1 ,3-dioxolane-4-carboxamide-substituted prepolymer i.e. a binder. Due to the possible selection of commercially available polyisocyanates and polyols a large number of such binders (prepolymers) can be prepared which, in turn, can be cured e.g. with commercially available amine hardeners.
• the present invention provides said 2-oxo-1 ,3-dioxolane-4-carboxamide- substituted prepolymer thus obtainable.
• IR (v [cm- 1 ]): 2977 bs (OH acid), 2751 bw, 2658 bw, 2621 bw, 2538 bw, 2407 bw, 1785 bm (CO cyclocarbonate), 1793 bs (CO acid), 1546 w, 1481 w, 1431 w, 1399 s, 1345 w, 1325 w, 128 m, 1 196 s, 1087 s, 1074 s, 1039 m, 928 w, 832 s, 769 s, 724 m, 699 s, 650 m, 633 s, 525 s.
• Example 8 Aerobic oxidation of glycerol carbonate (Reference)
• a 2-OXO-1 ,3-dioxolane-4-carboxamide building block on the basis of isophorone diiso- cyanate (IPDI) was prepared. Under an atmosphere of dry nitrogen, 3.33 g isophorone diisocyanate (IPDI) (0.015 mol) and 0.018 g (1 mol-%) 4-DMAP were dissolved in 10 ml of dry THF. 2.0 g 2-Oxo-[1 ,3]dioxolane-4-carboxylic acid (0.015 mol) was dissolved in 40 ml of dry THF and slowly added to the mixture via a dropping funnel.
• IPDI isophorone diiso- cyanate
• the reaction was stirred at room temperature for 24 h after which the solvent was evaporated and the product was obtained as yellow gel in almost quantitative yield.
• the gel was recrys- tallized from cyclohexane to give a white powder as a mixture of two isomers.
• Example 9 In the presence of DBTL (1 mol%), the resulting mixture of Example 9 could be reacted with Lupranol® 1000 to give a difunctional prepolymer.
• DBTL difunctional prepolymer
• 7.76 g (0.025 mol) of the product of Example 9 was dissolved in dry THF and 24.61 g Lupranol® 1000 (polypropylene glycol of BASF SE; 0.012 mol) and 0.10 g DBTL (0.16 mmol) was added and the reaction mixture was heated to 65°C for 2 h. After evaporation of the solvent, the product was obtained as yellowish to orange, slightly turbid oil as a mixture of isomers.
• Example 1 1 or 12 In the presence of DBTL (0.02 wt.-%), the resulting product of Example 1 1 or 12 could be reacted with hexane-1 ,6-diol to give a difunctional prepolymer.
• DBTL 0.02 wt.-%
• 5.0 g (0.019 mol) of said product was dissolved in dry THF and 1 .13 g hexane-1 ,6-diol (9.53 mmol) and 1 .2 mg DBTL (0.002 mmol) were added.
• the reaction mixture was heated to 60°C for 4 h. After evaporation of the solvent, the product was obtained as yellowish to brownish powder.
• the resulting bifunctional binder can be cured with different amines such as Lupasol FG ® (BASF SE), Polyetheramine T 403 or I PDA to give cured products. Curing time and film properties depend on the amine structure and can be tuned between several seconds (Lupasol FG) and several hours (T 403). Film properties vary from hard and brittle (Lupasol FG) to soft and elastic (T 403).
• amines such as Lupasol FG ® (BASF SE), Polyetheramine T 403 or I PDA
• a 2-OXO-1 ,3-dioxolane-4-carboxamide building block on the basis of Desmodur N 3600 (HDI-Trimer, Bayer AG, 23 % NCO) containing one cyclic carbonate functionality was prepared. Under an atmosphere of dry nitrogen, 15.0 g Desmodur N 3600 (0.082 mol NCO), 3.61 g 2-oxo-[1 ,3]-dioxolane-4-carboxylic acid (0.027 mol) and 0.04 g DBU were dissolved in 50 ml of dry THF and stirred at 25°C for 12 h. After evaporation of the solvent, the product was obtained as colorless oil in quantitative yield.
• NCO-content 1 1.3 % (theory: 14.2 %); H-NMR (THF-d 8 ): 7.79 (s, 1 H, NH), 5.02 (m, 1 H, cyclocarbonate), 4.65 (m, 1 H, cyclocarbonate), 4.49 (m, 1 H, cyclocarbonate), 3.87 (m, 6H, 3x CH 2 -N), 3.34 (t, 4H, 2x CH 2 -NCO), 3.26 (m, 2H, CH 2 -N-amide), 1 .67- 1 .37 (m, 24H, 12 x CH 2 ) ppm.
• a 2-OXO-1 ,3-dioxolane-4-carboxamide building block on the basis of Desmodur N 3600 (HDI-trimer, Bayer AG) containing two cyclic carbonate functionalities was prepared analogously.
• NCO-content 4.3 % (theory: 6.2 %); H-NMR (THF-d 8 ): 7.81 (s, 2H, NH), 5.05 (m, 2H, cyclocarbonate), 4.67 (m, 2H, cyclocarbonate), 4.50 (m, 2H, cyclocarbonate), 3.85 (m, 6H, 3x CHHM), 3.34 (t, 2H, CH 2 -NCO), 3.26 (m, 4H, CH 2 -N-amide), 1 .67- 1 .37 (m, 24H, 12 x CH 2 ) ppm.
• the free isocyanate group can be used for the preparation of oligo- functional binders via reaction with a di- or polyol.

Landscapes

• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Health & Medical Sciences (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Medicinal Chemistry (AREA)
• Polymers & Plastics (AREA)
• Polyurethanes Or Polyureas (AREA)
• Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
• Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Priority Applications (11)

Applications Claiming Priority (2)

Publications (1)

Family

ID=47630198

Family Applications (1)

Country Status (12)

Cited By (5)

Families Citing this family (7)

Citations (7)

Family Cites Families (9)

• 2013
  • 2013-01-31 EP EP13153383.8A patent/EP2762471A1/en not_active Withdrawn
• 2014
  • 2014-01-30 MX MX2015009852A patent/MX363692B/es unknown
  • 2014-01-30 EP EP14702016.8A patent/EP2951166B1/en active Active
  • 2014-01-30 AU AU2014211407A patent/AU2014211407B2/en not_active Ceased
  • 2014-01-30 WO PCT/EP2014/051784 patent/WO2014118268A1/en not_active Ceased
  • 2014-01-30 JP JP2015555703A patent/JP6338599B2/ja not_active Expired - Fee Related
  • 2014-01-30 ES ES14702016T patent/ES2792914T3/es active Active
  • 2014-01-30 US US14/760,834 patent/US9617238B2/en active Active
  • 2014-01-30 RU RU2015136648A patent/RU2674343C2/ru active
  • 2014-01-30 CA CA2896828A patent/CA2896828C/en active Active
  • 2014-01-30 BR BR112015014403-9A patent/BR112015014403B1/pt not_active IP Right Cessation
  • 2014-01-30 CN CN201480005232.4A patent/CN104918930B/zh active Active
• 2015
  • 2015-07-16 SA SA515360761A patent/SA515360761B1/ar unknown

Patent Citations (7)

Non-Patent Citations (2)

Also Published As

Similar Documents

Legal Events